Investor Presentation September 2026 Life-changing science PYC THERAPEUTICS The purpose of this presentation is to provide an update of the business of PYC Therapeutics Limited (ASX:PYC) [‘PYC’] . These slides have been prepared as a presentation aid only and the information they ...
Investor Webinar Presentation Q3 2026
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
In the deck
Earlier from PYC Therapeutics
- ADOA Program - Data Presentation
- Ceasing to be a substantial holder
- PKD - Presentation of Clinical Safety Data
- 2026 Corporate Governance Statement
- Appendix 4G
Later from PYC Therapeutics
- S&P DJI Announces September 2026 Quarterly Rebalance
- PKD - First Patient Dosed in OLE Study
- RP11 program - presentation at euretina 2026
- PKD Program - Presentation of Data at ASN Conference
- Notification of cessation of securities - PYC
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics